Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

United Therapeutic (UTHR)

United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,708,690
  • Shares Outstanding, K 43,057
  • Annual Sales, $ 2,877 M
  • Annual Income, $ 1,195 M
  • EBIT $ 1,494 M
  • EBITDA $ 1,566 M
  • 60-Month Beta 0.86
  • Price/Sales 7.09
  • Price/Cash Flow 16.70
  • Price/Book 3.10

Options Overview Details

View History
  • Implied Volatility 30.59% (-1.19%)
  • Historical Volatility 30.99%
  • IV Percentile 14%
  • IV Rank 8.91%
  • IV High 92.62% on 08/25/25
  • IV Low 24.53% on 12/17/24
  • Expected Move (DTE 15) 19.67 (4.06%)
  • Put/Call Vol Ratio 0.18
  • Today's Volume 86
  • Volume Avg (30-Day) 1,776
  • Put/Call OI Ratio 1.18
  • Today's Open Interest 28,874
  • Open Int (30-Day) 35,195
  • Expected Range 464.43 to 503.77

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 6.74
  • Number of Estimates 6
  • High Estimate 7.94
  • Low Estimate 5.79
  • Prior Year 6.19
  • Growth Rate Est. (year over year) +8.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
432.53 +11.92%
on 11/05/25
492.62 -1.73%
on 11/26/25
+46.77 (+10.69%)
since 11/04/25
3-Month
375.61 +28.88%
on 09/05/25
492.62 -1.73%
on 11/26/25
+103.63 (+27.24%)
since 09/04/25
52-Week
266.98 +81.32%
on 04/09/25
492.62 -1.73%
on 11/26/25
+109.70 (+29.30%)
since 12/04/24

Most Recent Stories

More News
2 Mooning Stocks on Our Buy List and 1 That Underwhelm

2 Mooning Stocks on Our Buy List and 1 That Underwhelm

CSCO : 77.76 (+0.01%)
UTHR : 484.10 (+0.65%)
HWM : 196.27 (+1.02%)
3 Market-Beating Stocks Worth Your Attention

3 Market-Beating Stocks Worth Your Attention

CECO : 55.62 (+2.06%)
RCL : 259.27 (-2.45%)
UTHR : 484.10 (+0.65%)
The Biotech Boom Gets a Trading Tool: How Direxion's Titans ETF Gives Access to the Sector's Top Performers

Amid the biotechnology sector's transformative era the Direxion Daily Biotech Top 5 Bull 2X ETF ($TBXU) offers traders a new, single-trade solution to gain 2X daily leveraged exposure to an e

ALNY : 465.34 (-1.68%)
EXEL : 44.37 (+0.82%)
GILD : 122.62 (-1.90%)
INSM : 205.04 (-0.84%)
UTHR : 484.10 (+0.65%)
3 Reasons Investors Love United Therapeutics (UTHR)

3 Reasons Investors Love United Therapeutics (UTHR)

UTHR : 484.10 (+0.65%)
The 5 Most Interesting Analyst Questions From United Therapeutics’s Q3 Earnings Call

The 5 Most Interesting Analyst Questions From United Therapeutics’s Q3 Earnings Call

UTHR : 484.10 (+0.65%)
United Therapeutics Corporation to Present at Upcoming Investor Conferences

United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, announced today that company executives will provide an overview and update on the company during fireside...

UTHR : 484.10 (+0.65%)
First clinical trial of pig kidney transplants gets underway

The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives

UTHR : 484.10 (+0.65%)
United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease

Ongoing EXPAND Study is the First Clinical Trial to Evaluate Xenotransplantation in End-Stage Renal Disease

UTHR : 484.10 (+0.65%)
2 Safe-and-Steady Stocks with Impressive Fundamentals and 1 We Avoid

2 Safe-and-Steady Stocks with Impressive Fundamentals and 1 We Avoid

COST : 895.85 (-2.86%)
OGN : 7.14 (-1.79%)
UTHR : 484.10 (+0.65%)
UTHR Q3 Deep Dive: Clinical Pipeline Advances and High-Dose Product Launches Drive Outlook

UTHR Q3 Deep Dive: Clinical Pipeline Advances and High-Dose Product Launches Drive Outlook

UTHR : 484.10 (+0.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by...

See More

Key Turning Points

3rd Resistance Point 496.75
2nd Resistance Point 491.61
1st Resistance Point 487.85
Last Price 484.10
1st Support Level 478.95
2nd Support Level 473.81
3rd Support Level 470.05

See More

52-Week High 492.62
Last Price 484.10
Fibonacci 61.8% 406.43
Fibonacci 50% 379.80
Fibonacci 38.2% 353.17
52-Week Low 266.98

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar